Treatment of inflammatory bowel disease (IBD).

Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 3

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract, which includes Crohn's disease (CD) and ulcerative colitis (UC). These diseases have become important health problems. Medical therapy for IBD has advanced dramatically in the last decade with the introduction of targeted biologic therapies, the optimization of older therapies, including rugs such as immunomodulators and 5-aminosalicylic acid (5-ASA), and a better understanding of the mucosal immune system and the genetics involved in the pathogenesis of IBD. The goal of IBD therapy is to induce and maintain remission. The current treatment paradigm involves a step-up approach, moving to aggressive, powerful therapies only when milder therapies with fewer potential side effects fail or when patients declare themselves to have an aggressive disease. This review focuses on the current treatments for inflammatory bowel disease.

Authors and Affiliations

Anand Pithadia, Sunita Jain

Keywords

Related Articles

Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex.

It has been postulated that hyperactive glycogen synthase kinase-3 (GSK-3) is an important factor in the pathogenesis of depression, and that this enzyme also contributes to the mechanism of antidepressant drug action. I...

Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice.

The low-molecular weight dipeptide bestatin is a potent inhibitor of aminopeptidase N and has been demonstrated to have antitumor and immunomodulatory effects. The effects of bestatin on interleukin (IL)-1β synthesis and...

Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.

Previous studies proved that food strongly enhanced the bioavailability of vinpocetine. Food may change the pharmacokinetics of a drug by affecting various factors, including gastrointestinal pH. However, the influence o...

Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors.

Preclinical data indicate the involvement of glutamatergic and serotonergic pathways in the antidepressant activity of zinc. The present study investigated alterations in N-methyl-D-aspartate (NMDA)/glutamatergic and ser...

Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.

The activity of the newly synthesized azaphenothiazines: tricyclic 10-substituted dipyridothiazines 1-9, pentacyclic 6-substituted diquinothiazines 10-22 and hexacyclic diquinothiazinium salt 23 was tested on 55-60 in vi...

Download PDF file
  • EP ID EP119223
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Anand Pithadia, Sunita Jain (2011). Treatment of inflammatory bowel disease (IBD).. Pharmacological Reports, 63(3), 629-642. https://europub.co.uk/articles/-A-119223